Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Journal of Neurology|April 2, 2022
The CCAS-scale in hereditary ataxias: helpful on the group level, particularly in SCA3, but limited in individual patientsAndreas Thieme, Jennifer Faber, Patricia Sulzer, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 25, 2025
A network perspective on cognition in individuals with Parkinson's diseaseDaniel Scharfenberg, Elke Kalbe, Monika Balzer-Geldsetzer, et al.
NPJ Parkinson'S Disease|April 6, 2026
Temporal dynamics of cognitive functioning in people with Parkinson's diseaseDaniel Scharfenberg, Elke Kalbe, Anja Ophey, et al.
Parkinsonism & Related Disorders|August 21, 2021
A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic "CERAD-Plus" tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE studyRobert Lillig, Anja Ophey, Jörg B Schulz, et al.
Journal of Neurology|July 1, 2024
Mid- and late-life lifestyle activities as main drivers of general and domain-specific cognitive reserve in individuals with Parkinson's disease: cross-sectional and longitudinal evidence from the LANDSCAPE studyAnja Ophey, Kathrin Wirtz, Steffen Wolfsgruber, et al.
Movement Disorders Clinical Practice|October 27, 2018
Standardized Assessment of Hereditary Ataxia Patients in Clinical StudiesBrigitte K Paap, Sandra Roeske, Alexandra Durr, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 13, 2016
Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE studyElke Kalbe, Sarah Petra Rehberg, Ines Heber, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 8, 2024
Automated remote speech-based testing of individuals with cognitive decline: Bayesian agreement of transcription accuracyAlexandra König, Stefanie Köhler, Johannes Tröger, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersHanna Boscheck, Maxie Liebscher, Ylenia D'Elia, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 20, 2021
Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessmentsAnja Ophey, Steffen Wolfsgruber, Sandra Roeske, et al.
Pageof 5